Jasper Therapeutics, Inc. (JSPR) News
Follow Jasper Therapeutics, Inc. (JSPR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 11 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Herb Cross to Resign as Jasper Therapeutics CFO; Jeet Mahal, Rick Ruiz and Matthew Ros Appointed to Interim Roles
Jasper Therapeutics's CFO Herb Cross will resign effective October 9, 2026; Jeet Mahal, Rick Ruiz and Matthew Ros were appointed to interim finance and corporate secretary roles.Original SEC Filing: Jasper Therapeutics,
REGULATION | Sep 28, 2026, 08:56 PM UTC
L
JSPR - Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
JSPR - Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
NEWS | Sep 15, 2026, 08:05 PM UTC
L
Jasper Therapeutics to present at H.C. Wainwright global investment conference
Jasper Therapeutics said management will participate at the H.C. Wainwright 28th Annual Global Investment Conference.
EQUITY | Sep 09, 2026, 12:01 PM UTC
L
JSPR - Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
JSPR - Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 09, 2026, 12:00 PM UTC
L
Jasper Therapeutics reports Q2 2026 results and corporate update
Jasper Therapeutics (JSPR) reports its second quarter 2026 financial results and provides a corporate update, according to TradeXchange Newsdesk.
EARNINGS | Aug 14, 2026, 03:00 PM UTC
M
Piper Initiates JSPR, LPTH, MRCY, UMAC Overweight
Piper initiates JSPR, LPTH, MRCY, UMAC at overweight, while JPM starts FLUT at neutral and Chardan starts QMLS at buy
EQUITY | Aug 12, 2026, 10:47 AM UTC
M
JSPR Initiated Overweight at Piper
JSPR initiated with Overweight rating at Piper with $2 price target
EQUITY | Aug 12, 2026, 09:44 AM UTC
H
Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu’s Fashion Considers Strategic Alternatives
New On The Block Lulu’s Fashion Lounge Holdings (NASDAQ: LVLU ) retained Solomon Partners as its financial advisor and Willkie Farr & Gallagher LLP as its legal advisor as the company evaluates strategic alternatives to
EARNINGS | Jul 17, 2026, 05:18 PM UTC
H
Why Callan JMB Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Shares of Callan JMB Inc (NASDAQ: CJMB ) rose sharply in pre-market trading following the announcement that Callan JMB signed a strategic partnership with Alabama State University to build an integrated pharmaceutical ma
MACRO | Jul 17, 2026, 08:48 AM UTC
L
JSPR - resumes trading after halt, +59% in AHs
JSPR - resumes trading after halt, +59% in AHs
EQUITY | Jul 16, 2026, 09:48 PM UTC
H
JSPR - PR: Jasper Therapeutics Announces Merger with Kira Pharmaceuticals -Combined company positioned to advance portfolio of biologic agen
JSPR - PR: Jasper Therapeutics Announces Merger with Kira Pharmaceuticals -Combined company positioned to advance portfolio of biologic agents designed to improve outcomes in patients with numerous immunologically-driven
MNA | Jul 16, 2026, 09:20 PM UTC